Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S267000, C540S580000, C544S252000
Reexamination Certificate
active
07067519
ABSTRACT:
The invention relates to novel 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as orexin receptor antagonists.
REFERENCES:
patent: 4460771 (1984-07-01), Meszaros et al.
patent: 4472398 (1984-09-01), Meszaros et al.
patent: 4588526 (1986-05-01), Hermecz et al.
patent: 4678499 (1987-07-01), Pasteris et al.
patent: 5753664 (1998-05-01), Aono et al.
patent: 6057315 (2000-05-01), Domagala et al.
patent: 6676976 (2004-01-01), Chattopadhyay et al.
patent: 6825184 (2004-11-01), Cirillo et al.
patent: 2003/0225111 (2003-12-01), Hennequin et al.
patent: 2004/0266798 (2004-12-01), Bavetsias
patent: WO-99/09024 (1999-02-01), None
patent: WO-99/58533 (1999-11-01), None
patent: WO-00/47576 (2000-08-01), None
patent: WO-00/47577 (2000-08-01), None
patent: WO-00/47580 (2000-08-01), None
patent: WO-01/85693 (2001-11-01), None
patent: WO-01/96302 (2001-12-01), None
patent: WO-02/44172 (2002-06-01), None
Kamal, A. et. al., “Chemoenzymatic Synthesis of Pyrrolo[2,1-b]quinazolinones: . . . ”, J. Org. Chem., 2001, vol. 66, pp. 997-1001.
Neal, Bramson H. ,“Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Deisign, Synthesis, Enxymatic Activities, and X-ray Crystallographic Analysis”, J.Med.Chem 2001, 44, pp. 4339-4358.
Bhardwaj, V., et al, “A Synthesis of 11H-Pyrido [2,1-b] Quinazolin-11-Ones,” Indian Journal of Heterocyclic Chemistry 1999, 9, pp. 173-176.
Karinov, A., “Synthesis of Methoxy-and Hydroxy-Substituted Deoxyvasicinones and Deoxypecanines,” Chemistry of Natural Compounds, 1982, 18, 4, pp. 466-472.
Giencke, A., “Desmethyl(trifluomethyl)actinomycine,” Liebigs Ann.Chem., 1990, pp. 569-179.
Chemelli R.M. et al., “Narcolepsy in orexin Knockout Mice: Molecular Genetics of Sleep Regulation,” Cell, 1999, 98, pp. 437-451.
Sakurai T., et al., “Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior,” Cell, 1998, 92, pp. 573-585.
Kamal, A. et al., “Chemoenzymatic Synthesis of Pyrrolo[2,1-b]quinazolinones: Lipase-Catalyzed Resolution of Vasicinone,” J. Org. Chem, 2001, 66, pp. 997-1001.
March J., “Aliphatic Nucleophilic Substitution,” Advanced Organic Chemistry-Reactions, Mechanisms and Structure, 1992, p. 418, 4th edition.
Follope, M.P., et al. “Synthese et etude de l'activite cytotoxique in vitro et antitumorale in vivo de nouvelles pyrrolo[2,1-c][1,4] benxodiazepines: partie I,” Eur. J.Med.Chem., 1992, 27, pp. 291-295.
Deady L.W., et al., “Synthesis and Antitumor Properties of N-[2-(Dimethylamino)ethyl]carboxamide Derivatives of Fused Tetracyclic Quinolines and Quinoxalines: A New Class of Putative Topoisomerase Inhibitors,” J.Med.Chem., 1997, 40, pp. 2040-2046.
Hughes, P., et al., “Synthetic Entries to 6-Fluoro-7-substituted Indole Derivatives,” J.Heterocyclic Chem, 1990, 27, pp. 2151-2163.
Rowley, M. et al., “3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systematically Active Anticonvulsants Acting by Antagonism at the Glycine Site of the N-Methyl-D-Aspartate Receptor Complex,” J.Med.Chem., 1993, 36, pp. 3386-3396.
Aissaoui Hamed
Clozel Martine
Fischli Walter
Koberstein Ralf
Sifferlen Thierry
Dickstein Shapiro Morin & Oshinsky LLP.
Truong Tamthom N.
Wilson James O.
LandOfFree
7,8,9,10-tetrahydro-6 H -azepino, 6,7,8,9-tetrahydro-pyrido... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7,8,9,10-tetrahydro-6 H -azepino, 6,7,8,9-tetrahydro-pyrido..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7,8,9,10-tetrahydro-6 H -azepino, 6,7,8,9-tetrahydro-pyrido... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3676567